Plasmapheresis as an adjunct to management of Rh isoimmunization.
Plasmapheresis as therapy for Rh isoimmunization has gained recent attention in Great Britain; however, this technique has not been widely accepted in the United States. At Wilford Hall USAF Medical Center, separator was beneficial in the management of a patient with Rh isoimmunization. A decrease in the delta optical density (OD) 450 followed the onset of plasmapheresis by 3 and 4 weeks and a correlation between the plasma anti-D concentration and the severity of the delta OD 450 was demonstrated.
D000328:Adult; D004899:Erythroblastosis, Fetal / Q000628:therapy*; D005260:Female; D006801:Humans; D010956:Plasmapheresis; D011247:Pregnancy